News
3h
Zacks Investment Research on MSNShould You Buy, Sell or Hold MRK Stock After Q1 Earnings Beat?Merck MRK reported its first-quarter 2025 results last week, beating estimates for both earnings and sales. Adjusted earnings of $2.22 per share rose 12% year over year, excluding foreign exchange ...
The Motley Fool. DATE Thursday, Apr 24, 2025 Read More: Earn up to $845 cash back this year just by changing how you pay at Costco! Learn more here. CALL PARTICIPANTS Rob Davis: Chairman and Chief ...
MSD is also bracing for a $200m hit due to tariffs as it accelerates US manufacturing and shifts its global supply strategy.
Merck said the expected tariff charge primarily reflects levies between the U.S. and China, but does not account for Trump’s planned pharmaceutical tariffs.
Although the company lowered its full-year outlook for adjusted earnings per share to between $8.82 and $8.97 from between $8.88 and $9.03, that was only because the new guidance included an expected ...
As measles cases continue to increase in the United States, this is what you should know about symptoms and your MMR vaccine ...
I'll admit: initially, I wasn't sold on the Pixel 9a's new hardware and design. The bezels are noticeably thick by today's standards – even when compared to similarly priced devices like the $459 ...
Merck is growing pharma sales and expanding margins, led by strong KEYTRUDA performance and cost discipline. Read more about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results